Results 21 to 30 of about 1,325,240 (268)

Microalbuminuria and cardiovascular risk [PDF]

QJM, 1998
The term 'microalbuminuria' has been introduced to describe a measurable increase in urine albumin excretion, which is still within normal total urine protein excretion levels. Many data suggest that microalbuminuria is of value as an index of vascular damage, especially in hypertension and diabetes, and there is increasing information on its ...
C, Lydakis, G Y, Lip
openaire   +2 more sources

Menopause and cardiovascular risk [PDF]

Pathophysiology of Haemostasis and Thrombosis, 2002
Menopause is not a disease, but a physiologic phase of a woman's life, due to the changes of their hormonal status. Fastidious symptoms may be associated with changes in the metabolism together with new cardiovascular risk factors, particularly aggressive for the female cardiovascular system, unprepared because of the protection due to the fertile ...
ROSSI, Rosario, T. GRIMALDI, G. ORIGLIANI, G. FANTINI, F. COPPI, MODENA, Maria Grazia   +5 more
openaire   +3 more sources

Use of a community advisory board to build equitable algorithms for participation in clinical trials: a protocol paper for HoPeNET

BMJ Health & Care Informatics, 2022
Introduction Participation from racial and ethnic minorities in clinical trials has been burdened by issues surrounding mistrust and access to healthcare.
Nicole Farmer, Valerie M Mitchell, Gwenyth R Wallen, Tiffany M Powell-Wiley, Allan Johnson, Foster Osei Baah, Faustine Williams, Erika Ortiz-Chapparo, Latifa Jackson, Billy Collins, Lennox Graham   +10 more
doaj   +1 more source

Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study

Biomedicines, 2022
In the last decades, high serum levels of lipoprotein(a) (Lp(a)) have been associated with increased cardiovascular disease (CVD) risk, in particular among individuals with smaller apolipoprotein(a) (apo(a)) isoforms than those with larger sizes. The aim
Arrigo F. G. Cicero, Federica Fogacci, Giuseppe Derosa, Angela D’Angelo, Fulvio Ventura, Elisabetta Rizzoli, Sergio D’Addato, Claudio Borghi, on behalf of the Brisighella Heart Study Group   +8 more
doaj   +1 more source

Use of human PBMC to analyse the impact of obesity on lipid metabolism and metabolic status: a proof-of-concept pilot study

Scientific Reports, 2021
Peripheral blood mononuclear cells (PBMC) are widely used as a biomarker source in nutrition/obesity studies because they reflect gene expression profiles of internal tissues.
Andrea Costa, Bàrbara Reynés, Jadwiga Konieczna, Marian Martín, Miquel Fiol, Andreu Palou, Dora Romaguera, Paula Oliver   +7 more
doaj   +1 more source

Hypoglycemia and Cardiovascular Risks

Diabetes Care, 2011
Although hypoglycemia is the most common side effect of insulin therapy in diabetes and its morbidity is well known, for many years, the potentially life-threatening effects of hypoglycemia on the cardiovascular (CV) system have either been overlooked or have been dismissed as inconsequential to people with insulin-treated type 2 diabetes.
Frier, B.M., Schernthaner, G., Heller, S.R.   +2 more
openaire   +3 more sources

NSAIDs and cardiovascular risk [PDF]

Kidney International, 2014
To the Editor: In the recent article by Wei et al.,1 it was concluded that nonsteroidal anti-inflammatory drug (NSAID) prescribing decreased after the introduction of estimated glomerular filtration rate (eGFR) reporting in April 2006 within primary care.
Bell, Samira, Marwick, Charis A
openaire   +3 more sources

Residual cardiovascular risk [PDF]

European Heart Journal Supplements, 2016
Residual cardiovascular risk is often associated with lipid abnormalities, such as atherogenic dyslipidaemia (AD). Dyslipidaemias are one of the determinants of the risk of developing atherosclerotic cardiovascular disease. In addition to low-density lipoprotein (LDL) particles, which are the most atherogenic lipoproteins, other apolipoprotein B ...
FERRARI, Roberto, Catapano, Alberico L.
openaire   +2 more sources

Immune cell phenotyping in low blood volumes for assessment of cardiovascular disease risk, development, and progression: a pilot study

Journal of Translational Medicine, 2020
Background Cardiovascular disease (CVD) is the leading cause of death in the world. Given the role of immune cells in atherosclerosis development and progression, effective methods for characterizing immune cell populations are needed, particularly among
Yvonne Baumer, Cristhian A. Gutierrez-Huerta, Ankit Saxena, Pradeep K. Dagur, Steven D. Langerman, Kosuke Tamura, Joniqua N. Ceasar, Marcus R. Andrews, Valerie Mitchell, Billy S. Collins, Quan Yu, Heather L. Teague, Martin P. Playford, Christopher K. E. Bleck, Nehal N. Mehta, J. Philip McCoy, Tiffany M. Powell-Wiley   +16 more
doaj   +1 more source

Multilevel mobile health approach to improve cardiovascular health in resource-limited communities with Step It Up: a randomised controlled trial protocol targeting physical activity

BMJ Open, 2020
Introduction Although physical activity (PA) reduces cardiovascular disease (CVD) risk, physical inactivity remains a pressing public health concern, especially among African American (AA) women in the USA.
Sophie E Claudel, Joniqua N Ceasar, Marcus R Andrews, Valerie M Mitchell, Kosuke Tamura, Gwenyth R Wallen, Nithya P Vijayakumar, James F Troendle, Kaveri Curlin, Sam J Neally, Billy S Collins, Yvonne Baumer, Cristhian A Gutierrez-Huerta, Rafique Islam, Briana S Turner, Kathryn G Tippey, Shayne Giuliano, Regina McCoy, Jessica Zahurak, Sharon Lambert, Philip J Moore, Mary Douglas-Brown, Tonya Dodge, Tiffany M Powell-Wiley   +23 more
doaj   +1 more source